Ascendis Pharma A/S (Nasdaq: ASND) announced that its Board of Directors has authorized the Company to repurchase up to $25 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE